A Study of QLS5133 Monotherapy in Advanced Solid Tumors
Clinical trial NCT07061639 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07061639
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2027-07-01
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.